|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
US6628343B1
(en)
|
1997-05-23 |
2003-09-30 |
Sony Corporation |
Television signal reception circuit, automatic phase shift control circuit and equal amplitude addition circuit
|
|
HUP0104634A3
(en)
|
1998-07-06 |
2002-11-28 |
Bristol Myers Squibb Co |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
CA2416384A1
(en)
|
2000-07-17 |
2003-01-16 |
Takeda Chemical Industries, Ltd. |
Sulfone derivatives, their production and use
|
|
CN1642599A
(zh)
|
2002-02-27 |
2005-07-20 |
辉瑞产品公司 |
Acc抑制剂
|
|
KR101025633B1
(ko)
|
2002-09-19 |
2011-03-30 |
일라이 릴리 앤드 캄파니 |
오피오이드 수용체 안타고니스트로서의 디아릴 에테르
|
|
AU2003278600A1
(en)
|
2002-11-01 |
2004-05-25 |
Takeda Pharmaceutical Company Limited |
Agent for preventing or treating neuropathy
|
|
CA2505322A1
(en)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
US20070004736A1
(en)
|
2002-11-22 |
2007-01-04 |
Keiji Kubo |
Imidazole derivative, process for producing the same, and use
|
|
US7777051B2
(en)
|
2003-05-13 |
2010-08-17 |
Icagen, Inc. |
Asymmetric benzimidazoles and related compounds as potassium channel modulators
|
|
EP1630152A4
(en)
|
2003-05-30 |
2009-09-23 |
Takeda Pharmaceutical |
CONDENSED CYCLIC COMPOUND
|
|
EP1669352A4
(en)
|
2003-09-30 |
2008-12-17 |
Takeda Pharmaceutical |
THIAZOLINE DERIVATIVE AND ITS USE
|
|
EP1695961A4
(en)
|
2003-12-17 |
2007-10-24 |
Takeda Pharmaceutical |
UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
|
|
ATE461217T1
(de)
|
2003-12-18 |
2010-04-15 |
Novo Nordisk As |
Glp-1-verbindungen
|
|
AU2004309271A1
(en)
|
2003-12-25 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl)propanoic acid derivatives
|
|
WO2005063725A1
(ja)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
フェニルプロパン酸誘導体
|
|
JP4875978B2
(ja)
|
2004-03-15 |
2012-02-15 |
武田薬品工業株式会社 |
アミノフェニルプロパン酸誘導体
|
|
US7517910B2
(en)
|
2004-03-30 |
2009-04-14 |
Takeda Pharmaceutical Company Limited |
Alkoxyphenylpropanoic acid derivatives
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
AP2006003768A0
(en)
|
2004-05-25 |
2006-10-31 |
Pfizer Prod Inc |
TetraazabenzoÄeÜazulene derivatives and analogs tehereof
|
|
US20050287100A1
(en)
|
2004-06-08 |
2005-12-29 |
Lebre Caroline |
Cosmetic composition comprising a semi-crystalline polymer and a dispersion of polymer in fatty phase
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
US20090054435A1
(en)
|
2005-07-29 |
2009-02-26 |
Hiroshi Imoto |
Phenoxyalkanoic Acid Compound
|
|
TW200740435A
(en)
|
2005-08-10 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Therapeutic agent for diabetes
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
EP2010520B1
(en)
|
2006-04-20 |
2012-09-12 |
Pfizer Products Inc. |
Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
|
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
|
RS53230B
(sr)
|
2006-06-27 |
2014-08-29 |
Takeda Pharmaceutical Company Limited |
Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
|
RU2454415C9
(ru)
|
2006-10-19 |
2013-02-27 |
Такеда Фармасьютикал Компани Лимитед |
Производное индола
|
|
BRPI0721053A2
(pt)
|
2006-11-29 |
2014-07-29 |
Pfizer Prod Inc |
INIBIDORES DE ESPIROCETONA ACETIL-CoA CARBOXILASE
|
|
EP2128138A1
(en)
|
2007-01-29 |
2009-12-02 |
Takeda Pharmaceutical Company Limited |
Pyrazole compound
|
|
JP2010517935A
(ja)
|
2007-02-09 |
2010-05-27 |
武田薬品工業株式会社 |
Ｐｐａｒ−ガンマのパーシャルアゴニストとしての縮合環化合物
|
|
JPWO2008136428A1
(ja)
|
2007-04-27 |
2010-07-29 |
武田薬品工業株式会社 |
含窒素５員複素環化合物
|
|
KR20090130345A
(ko)
|
2007-05-04 |
2009-12-22 |
아이알엠 엘엘씨 |
Ｃ-ｋｉｔ 및 ｐｄｇｆｒ 키나제 억제제로서의 화합물 및 조성물
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
WO2008156757A1
(en)
|
2007-06-19 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Indazole compounds for activating glucokinase
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
CL2009001214A1
(es)
|
2008-05-19 |
2010-12-31 |
Schering Corp |
Compuestos derivados de heterociclo, moduladores de serina proteasas composicion fa<rmacaeutica que los comprende; y su uso en el tratamiento de trastornos tromboembolicos
|
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
WO2009144555A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
CN102105159B
(zh)
|
2008-06-17 |
2015-07-08 |
印第安纳大学研究及科技有限公司 |
基于gip的混合激动剂用于治疗代谢紊乱和肥胖症
|
|
JP2011529483A
(ja)
|
2008-07-29 |
2011-12-08 |
ファイザー・インク |
フッ素化ヘテロアリール
|
|
AU2009286380B2
(en)
|
2008-08-28 |
2011-09-15 |
Pfizer Inc. |
Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
|
|
WO2010065674A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
CA2754685A1
(en)
|
2009-03-11 |
2010-09-16 |
Pfizer Inc. |
Substituted indazole amides
|
|
EP2604604A1
(en)
|
2009-03-11 |
2013-06-19 |
Pfizer Inc |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
US20120052130A1
(en)
|
2009-05-08 |
2012-03-01 |
Pfizer Inc. |
Gpr 119 modulators
|
|
CA2759843A1
(en)
|
2009-05-08 |
2010-11-10 |
Pfizer Inc. |
Gpr 119 modulators
|
|
NZ596467A
(en)
|
2009-06-05 |
2014-01-31 |
Pfizer |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8420655B2
(en)
|
2009-12-04 |
2013-04-16 |
Boehringer Ingelheim International Gmbh |
Benzimidazole inhibitors of leukotriene production
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
JP6126097B2
(ja)
|
2011-09-06 |
2017-05-10 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１誘導体
|
|
CN109867630A
(zh)
|
2013-06-11 |
2019-06-11 |
赛尔基因第二国际有限公司 |
新型glp-1受体调节剂
|
|
CA2955836C
(en)
|
2014-07-25 |
2023-02-14 |
Celgene International Ii Sarl |
Glp-1 receptor modulators
|
|
EP3225618B1
(en)
|
2014-11-26 |
2020-05-06 |
Takeda Pharmaceutical Company Limited |
Bicyclic compound
|
|
SG11201805586SA
(en)
|
2015-12-31 |
2018-07-30 |
Hanmi Pharmaceutical Co Ltd |
Triple glucagon/glp-1/gip receptor agonist
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
JOP20190060A1
(ar)
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
CN108430998B
(zh)
|
2016-09-28 |
2021-07-09 |
四川科伦博泰生物医药股份有限公司 |
氮杂双环衍生物及其制备方法和用途
|
|
CN108017636A
(zh)
|
2016-11-04 |
2018-05-11 |
合帕吉恩治疗公司 |
作为fxr调节剂的含氮杂环化合物
|
|
KR102314286B1
(ko)
*
|
2016-12-16 |
2021-10-21 |
화이자 인코포레이티드 |
Glp-1 수용체 작용제 및 이의 용도
|
|
US11136324B2
(en)
|
2017-03-03 |
2021-10-05 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors
|
|
US10934279B2
(en)
|
2018-06-13 |
2021-03-02 |
Pfizer Inc. |
GLP-1 receptor agonists and uses thereof
|
|
DK3806855T5
(da)
|
2018-06-15 |
2023-05-22 |
Pfizer |
GLP-1-receptoragonister og anvendelser deraf
|
|
US11254660B2
(en)
|
2018-08-31 |
2022-02-22 |
Pfizer Inc. |
Combinations for treatment of NASH/NAFLD and related diseases
|
|
MA54555A
(fr)
|
2018-11-22 |
2021-09-29 |
Qilu Regor Therapeutics Inc |
Agonistes de glp-1r et leurs utilisations
|
|
CN113365637A
(zh)
|
2018-12-05 |
2021-09-07 |
维京治疗公司 |
用于治疗肝部病症的组合物和方法
|
|
EP3953344A4
(en)
|
2019-04-12 |
2023-08-09 |
Qilu Regor Therapeutics Inc. |
GLP-IR AGONISTS AND THEIR USES
|
|
WO2020234726A1
(en)
|
2019-05-20 |
2020-11-26 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
EP4048664A1
(en)
|
2019-10-25 |
2022-08-31 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2021096284A1
(ko)
|
2019-11-15 |
2021-05-20 |
일동제약(주) |
Glp-1 수용체 작용제 및 이의 용도
|
|
CN114761395B
(zh)
|
2019-12-02 |
2024-11-15 |
现代药品株式会社 |
Glp-1受体激动剂
|
|
ES3016132T3
(en)
|
2020-01-29 |
2025-05-08 |
Gilead Sciences Inc |
Glp-1r modulating compounds
|
|
JP7836762B2
(ja)
|
2020-02-13 |
2026-03-27 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
IL296336A
(en)
|
2020-03-18 |
2022-11-01 |
Lg Chemical Ltd |
Glp-1 receptor agonist, pharmaceutical composition comprising same, and method for preparing same
|
|
CN113493447B
(zh)
|
2020-04-03 |
2024-06-11 |
轩竹(北京)医药科技有限公司 |
Glp-1受体激动剂
|
|
TW202144340A
(zh)
|
2020-04-03 |
2021-12-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
|
|
TW202206429A
(zh)
|
2020-04-29 |
2022-02-16 |
美商迦舒布魯姆生物有限公司 |
雜環ｇｌｐ—１促效劑
|
|
MX2022015026A
(es)
|
2020-06-04 |
2023-01-04 |
Hangzhou Sciwind Biosciences Co Ltd |
Compuesto heteroaromatico de imidazol de cinco miembros y uso del mismo.
|
|
CN115697338B
(zh)
|
2020-06-10 |
2024-08-09 |
东宝紫星(杭州)生物医药有限公司 |
甲基取代的苯并二噁唑类化合物及其应用
|
|
CN117645601A
(zh)
|
2020-06-10 |
2024-03-05 |
重庆康丁医药技术有限公司 |
一种具有心血管益处的glp-1小分子
|
|
CN113801136B
(zh)
|
2020-06-16 |
2023-04-07 |
江苏恒瑞医药股份有限公司 |
咪唑并杂芳基类衍生物、其制备方法及其在医药上的应用
|
|
CN113816948B
(zh)
|
2020-06-19 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
稠合咪唑类衍生物、其制备方法及其在医药上的应用
|
|
CN115916772B
(zh)
|
2020-06-19 |
2025-01-14 |
江苏恒瑞医药股份有限公司 |
6-氧代-3,6-二氢吡啶类衍生物、其制备方法及其在医药上的应用
|
|
CN113831337B
(zh)
|
2020-06-24 |
2023-03-24 |
广州市恒诺康医药科技有限公司 |
Glp-1受体激动剂及其药物组合物和用途
|
|
WO2022031994A1
(en)
|
2020-08-06 |
2022-02-10 |
Qilu Regor Therapeutics Inc. |
Glp-1r agonists and uses thereof
|
|
JP2023537501A
(ja)
|
2020-08-06 |
2023-09-01 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
CA3192601A1
(en)
|
2020-08-21 |
2022-02-24 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|
|
EP4204415A4
(en)
|
2020-08-28 |
2025-03-26 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
CA3188891A1
(en)
|
2020-09-01 |
2022-01-13 |
Fanglong Yang |
Fused imidazole derivative, preparation method therefor, and medical use thereof
|
|
EP4211133A4
(en)
|
2020-09-07 |
2024-11-27 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
WO2022068772A1
(zh)
|
2020-09-29 |
2022-04-07 |
深圳信立泰药业股份有限公司 |
一种苯并咪唑类衍生物及其制备方法和医药用途
|
|
WO2022078152A1
(zh)
|
2020-10-12 |
2022-04-21 |
杭州中美华东制药有限公司 |
苯并咪唑酮类glp-1受体激动剂及其用途
|
|
EP4229050A4
(en)
|
2020-10-13 |
2024-12-11 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
US20240083886A1
(en)
|
2020-10-13 |
2024-03-14 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
MX2023006186A
(es)
|
2020-11-27 |
2023-08-07 |
Shenzhen Salubris Pharm Co Ltd |
Derivado de benzimidazol y método de preparación del mismo y uso médico del mismo.
|
|
CN114591296A
(zh)
|
2020-12-02 |
2022-06-07 |
海思科医药集团股份有限公司 |
一种glp-1r激动剂及其在医药上的应用
|
|
CN114591308B
(zh)
|
2020-12-03 |
2024-03-08 |
苏州闻泰医药科技有限公司 |
一类glp-1r受体激动剂化合物及其用途
|
|
CN114634510B
(zh)
|
2020-12-16 |
2025-11-04 |
杭州中美华东制药有限公司 |
咪唑并吡啶衍生物及其用途
|
|
WO2022135572A1
(zh)
|
2020-12-25 |
2022-06-30 |
四川海思科制药有限公司 |
一种五并五元环衍生物及其在医药上的应用
|
|
CN114763352A
(zh)
|
2021-01-15 |
2022-07-19 |
海思科医药集团股份有限公司 |
一种glp-1受体激动剂及其在医药上的应用
|
|
CR20230330A
(es)
|
2021-01-28 |
2023-11-15 |
Carmot Therapeutics Inc |
Agonistas del receptor gpcr, composiciones farmaceuticas que los comprenden y métodos para su uso
|
|
CN114907351A
(zh)
|
2021-02-07 |
2022-08-16 |
杭州中美华东制药有限公司 |
三环类glp-1受体激动剂及其用途
|
|
EP4304712A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2022192428A1
(en)
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
US20240208952A1
(en)
|
2021-03-22 |
2024-06-27 |
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. |
Thiophene glp-1 receptor agonist and use thereof
|
|
JP7772778B2
(ja)
|
2021-03-24 |
2025-11-18 |
塩野義製薬株式会社 |
縮合環を有するｇｌｐ－１受容体作動薬を含有する医薬組成物
|
|
CN117222631A
(zh)
|
2021-03-24 |
2023-12-12 |
诚益生物(美国)公司 |
苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-苯基-、苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-杂芳基-或苯基-[1,3]二氧杂环戊烯并[4,5-c]吡啶基-哌啶基-甲基-氧杂环丁烷基甲基-1h-苯并[d]咪唑-甲酸衍生物及其使用方法
|
|
WO2022216094A1
(ko)
|
2021-04-08 |
2022-10-13 |
주식회사 엘지화학 |
Glp-1 수용체 효능제, 이를 포함하는 약학적 조성물 및 이의 제조방법
|
|
WO2022219495A1
(en)
|
2021-04-12 |
2022-10-20 |
Novartis Ag |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|
|
CN117177970A
(zh)
|
2021-04-30 |
2023-12-05 |
上海翰森生物医药科技有限公司 |
多环类衍生物调节剂、其制备方法和应用
|
|
CN115594669B
(zh)
|
2021-07-09 |
2024-11-05 |
深圳信立泰药业股份有限公司 |
一种并环类衍生物及其制备方法和医药用途
|
|
CN113480534B
(zh)
|
2021-07-23 |
2022-05-13 |
广州必贝特医药股份有限公司 |
苯并咪唑或氮杂苯并咪唑-6-羧酸类化合物及其应用
|
|
EP4469444A4
(en)
|
2022-01-24 |
2026-01-07 |
Gasherbrum Bio Inc |
GLP-1 HETEROCYCLIC AGONISTS
|
|
JP2025506474A
(ja)
|
2022-02-09 |
2025-03-11 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
US20250177362A1
(en)
|
2022-02-09 |
2025-06-05 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
US20250206757A1
(en)
|
2022-03-21 |
2025-06-26 |
Gasherbrum Bio, Inc. |
5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
|
|
US20250250269A1
(en)
|
2022-04-14 |
2025-08-07 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
CN114716423A
(zh)
|
2022-05-20 |
2022-07-08 |
中国科学院上海药物研究所 |
5,6-二氢-1,2,4-三嗪类化合物及其作为glp-1受体激动剂的药学用途
|
|
US12419556B2
(en)
|
2022-08-31 |
2025-09-23 |
Hong Kong Applied Science and Technology Research Institute Company Limited |
Method and system for detecting short-term stress and generating alerts inside the indoor environment
|